Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce the achievement of a major operational and commercial milestone: over 200,000 EEG/ERP (human brain function) scans.

Through its acquisition of Evoke Neuroscience, Inc. in May 2025, combined with the successful execution of its key internal growth initiatives, Firefly has now driven 5%, 11%, 15%, and 17% sequential EEG/ERP brain scan volume growth, respectively, over the past four quarters.